VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Perseus SENOLYTIX

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

A New Class of Cancer Therapeutics Targeting the Inner Mitochondrial Membrane

  • Biotech & therapeutics
Status
Operatingas of 2026-09-19
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Perseus SENOLYTIX is an oncology company developing this unique subset of MitoXcel geropeptides, that we now call MitoXcel oncopeptides, to treat cancer via this same novel target, although via a cancer-specific mechanism, as a potentially safe and effective new class of cancer therapeutics.

Products

Other
MitoXcel oncopeptides
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy